ArticleOncotarget2017

Significant benefit of Nivolumab treating PD-L1 positive metastatic pulmonary carcinosarcoma: a case report and literature review.

Zhe Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.